skip to Main Content

News

Latest News, Announcements, and Press Releases

10May 18

Codexis Reports First Quarter 2018 Financial Results

Total revenues increase 76% to $14.0 million on sharply higher R&D revenue Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , May 10, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces…
read more
23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

View translation: Japanese | Simplified Chinese | Traditional Chinese Redwood City, Calif., and Chongqing, China (April 23, 2018) – Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology…
read more
23Apr 18

Porton Pharma Solutions and Codexis Launch Global Partnership

REDWOOD CITY, Calif. & CHONGQING, China –(BUSINESS WIRE)–Apr. 23, 2018– Codexis, Inc. (NASDAQ: CDXS) and Porton Pharma Solutions, Ltd. (SZSE: 300363) announce a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active
read more
05Apr 18

Codexis Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif. , April 05, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 3,750,000 shares of its common stock at a public offering price of $9.25…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins® with Codexis

Back To Top
Close search
Search